GLP-1 receptor agonists (GLP-1RAs), novel agents that are dual and triple hormonal agonists, have emerged as valuable therapeutic agents for managing obesity and type 2 diabetes [1]. Here, GLP1R is linked to type 2 diabetes mellitus.